NCT04923503

Brief Summary

Diabetes Mellitus individuals are known to have dietary rules, namely regulating the amount, type and time of eating. Ramadan fasting seems to be beneficial for people who want to reduce their weight, but it is not easy for diabetic patients. Because of its distinctive features, Ramadhan induces changes in eating habits, calorie consumption, sleeping patterns, and daily physical activity, which may contribute to changes in hunger-satiety responses and glicemic control. Examining changes in gut hormones during Ramadan fasting may reveal whether this observance could change glucose metabolism in diabetics without triggering the undesirable effect of gluconeogenesis. The proportions of fat, protein, and carbohydrate in meals vary between outside and within Ramadan. Alterations in timing and composition meal during Ramadan lead to reduced food intake may affect gut hormones and metabolic responses. The aim of this study to determine whether the effect of Ramadan fasting differed in people with DM patients, pre-DM and healthy individuals, with respect to gut hormones, body composition, metabolic parameters, and glycemic control

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2021

Completed
19 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 6, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 11, 2021

Completed
Last Updated

June 29, 2021

Status Verified

June 1, 2021

Enrollment Period

1 month

First QC Date

June 6, 2021

Last Update Submit

June 26, 2021

Conditions

Keywords

gut hormonesmetabolic parametersobesityleandiabeticsramadan fasting

Outcome Measures

Primary Outcomes (4)

  • change acylated ghrelin

    Change from Baseline acyl ghrelin at 30 days taken in the lab from venous blood specimen

    30 days

  • change PYY

    Change from Baseline PYY at 30 days taken in the lab from venous blood specimen

    30 days

  • change GLP-1

    Change from Baseline GLP-1 at 30 days taken in the lab from venous blood specimen

    30 days

  • change insulin

    Change from Baseline Insulin at 30 days taken in the lab from venous blood specimen

    30 days

Secondary Outcomes (1)

  • change body weight

    30 days

Study Arms (3)

lean ramadan fasting

EXPERIMENTAL

conduct ramadan fasting for 30 days

Behavioral: diurnal fasting

obese ramadan fasting

EXPERIMENTAL

conduct ramadan fasting for 30 days

Behavioral: diurnal fasting

diabetics ramadan fasting

EXPERIMENTAL

conduct ramadan fasting for 30 days

Behavioral: diurnal fasting

Interventions

diurnal fastingBEHAVIORAL

subject conduct fasting in Ramadan for 30 days

Also known as: ramadan fasting
diabetics ramadan fastinglean ramadan fastingobese ramadan fasting

Eligibility Criteria

Age35 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Diabetics subjects: glucose fasting plasma \> 200 mg/dL, with aged 35-60 years and body mass index above 25 kg/m;
  • Obese subjects: body mass index above 25 kg/m2 with aged 35-60 years and waist circumference for men \>90 cm, for women \> 80 cm
  • Lean subjects: body mass index below 23.5 kg/m2 with aged 35-60 years and waist circumference for men \<90 cm, for women \< 80 cm

You may not qualify if:

  • experienced weight loss more than 10% from the actual weight in the last three months
  • consumed medicine or supplement for weight loss diet, •. had the history of evidence of clinical depression, cognitive disorders, heart disease, cancer, liver or renal disease, chronic pulmonary disease, uncontrolled hypertension, physical disability, or other contraindications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Etika Ratna Noer

Semarang, Central Java, 50275, Indonesia

Location

MeSH Terms

Conditions

FastingObesity

Condition Hierarchy (Ancestors)

Feeding BehaviorBehaviorOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Etika R Noer

    Diponegoro University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
subject with random allocation Investigator do not know the group the analysator do not know the group
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: three arm parallel group with 45 subjects: 1. fasting in lean group 2. fasting in obese group 3. fasting in diabetics group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Nutrition, Medical Faculty

Study Record Dates

First Submitted

June 6, 2021

First Posted

June 11, 2021

Study Start

March 1, 2021

Primary Completion

April 12, 2021

Study Completion

May 1, 2021

Last Updated

June 29, 2021

Record last verified: 2021-06

Data Sharing

IPD Sharing
Will share

the result of this study is available to cite everyone

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
anytime
Access Criteria
etikaratna@fk.undip.ac.id
More information

Locations